- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04325139
External Validation of a Predictive Model for Bowel Preparation in Patients Undergoing Colonoscopy
July 26, 2020 updated by: Yanglin Pan, Air Force Military Medical University, China
Bowel preparation is closely lined to the quality of colonoscopy, inadequate bowel preparation (IBP) could lead to higher miss rate of adenomas, patients' discomfort and higher health expense.
For the patients with possible IBP before the examination, it may be better to cancel the colonoscopy and repeat bowel preparation through modified or enhanced strategies.
This study aimed to externally validate the efficiency of a procedure-based model in predicting inadequate bowel preparation
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
600
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fujian
-
Xiamen, Fujian, China, 361000
- Department of Gastroenterology, Hongai Hospital
-
Xiamen, Fujian, China
- Xiang'an Hospital of Xiamen University
-
-
Hainan
-
Qionghai, Hainan, China
- Department of Gastroenterology, Qionghai people's hospital
-
-
Hebei
-
Shijiazhuang, Hebei, China
- Department of Gastroenterology, Bethune international peace hospital
-
-
Henan
-
Zhengzhou, Henan, China
- Department of Gastroenterology,Zhengzhou Central Hospital
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710005
- Department of gastroenterology, Shaanxi Second People's Hospital
-
Xi'an, Shaanxi, China, 710032
- Endoscopic center, Xijing Hospital of Digestive Diseases
-
Xi'an, Shaanxi, China
- The Second Affiliated Hospital of Xi'an Jiaotong University
-
-
Shannxi
-
Xi'an, Shannxi, China
- The First Affiliated Hospital of Xi'an Medical University
-
-
Shanxi
-
Taiyuan, Shanxi, China
- Department of Gastroenterology,Shanxi Bethune hospital
-
-
Sichuang
-
Chengdu, Sichuang, China
- Department of Gastroenterology,Chengdu third people's hospital
-
-
Xinjiang
-
Shihezi, Xinjiang, China, 832008
- Department of Gastroenterology, The First Affiliated Hospital of the Medical College, Shihezi University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
This is a prospective study involving eleven tertiary-centers in China.
Description
Inclusion Criteria:
- Age≥18
- Patient undergoing colonoscopy
Exclusion Criteria:
- Patients with prior colectomy
- Unable to provide written informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adequate bowel preparation
Time Frame: 1 hour
|
Defined by each segmental BBPS≥2
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The rate of yellow, clear stool in the last defecation
Time Frame: 1 hour
|
The characteristics of the last stool was self-evaluated by patients based on a picture containing different kind of stool examples.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 23, 2020
Primary Completion (Actual)
May 30, 2020
Study Completion (Actual)
June 30, 2020
Study Registration Dates
First Submitted
March 26, 2020
First Submitted That Met QC Criteria
March 26, 2020
First Posted (Actual)
March 27, 2020
Study Record Updates
Last Update Posted (Actual)
July 28, 2020
Last Update Submitted That Met QC Criteria
July 26, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- KT20200324-3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.